BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jose FA, Heyman MB. Extraintestinal manifestations of inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2008;46:124-133. [PMID: 18223370 DOI: 10.1097/mpg.0b013e318093f4b0] [Cited by in Crossref: 48] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Gaur L, Aggarwal G, Mazumder S, Khanna A, Singhal MK. Thrombotic Thrombocytopenic Purpura and Ulcerative Colitis - A Potential Link Revisited. Indian J Nephrol 2021;31:492-4. [PMID: 34880563 DOI: 10.4103/ijn.IJN_236_20] [Reference Citation Analysis]
2 Varga G, Ugocsai M, Hartmann P, Lajkó N, Molnár R, Szűcs S, Jász DK, Érces D, Ghyczy M, Tóth G, Boros M. Acetylsalicylic acid-tris-hydroxymethyl-aminomethane reduces colon mucosal damage without causing gastric side effects in a rat model of colitis. Inflammopharmacology 2018;26:261-71. [PMID: 28451776 DOI: 10.1007/s10787-017-0354-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
3 Mahdinejad-Yazdi M, Sobhan MR, Dastgheib SA, Bahrami R, Shaker SH, Mirjalili H, Sadeghizadeh-Yazdi J, Zare-Shehneh M, Neamatzadeh H. A meta-analysis for association of TNF-α -308G>A polymorphism with susceptibility to Ankylosing Spondylitis. J Orthop 2021;26:79-87. [PMID: 34349398 DOI: 10.1016/j.jor.2021.07.015] [Reference Citation Analysis]
4 Gurcay E, Akinci A. Autoinflammatory Diseases and Physical Therapy. Mediterr J Rheumatol 2017;28:183-91. [PMID: 32185281 DOI: 10.31138/mjr.28.4.183] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Ferrusquía J, Pérez-Martínez I, Gómez de la Torre R, Fernández-Almira ML, de Francisco R, Rodrigo L, Riestra S. Gastroenterology case report of mesalazine-induced cardiopulmonary hypersensitivity. World J Gastroenterol 2015; 21(13): 4069-4077 [PMID: 25852295 DOI: 10.3748/wjg.v21.i13.4069] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
6 Vutcovici M, Brassard P, Bitton A. Inflammatory bowel disease and airway diseases. World J Gastroenterol 2016; 22(34): 7735-7741 [PMID: 27678355 DOI: 10.3748/wjg.v22.i34.7735] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
7 Wangchuk P, Shepherd C, Constantinoiu C, Ryan RYM, Kouremenos KA, Becker L, Jones L, Buitrago G, Giacomin P, Wilson D, Daly N, McConville MJ, Miles JJ, Loukas A. Hookworm-Derived Metabolites Suppress Pathology in a Mouse Model of Colitis and Inhibit Secretion of Key Inflammatory Cytokines in Primary Human Leukocytes. Infect Immun 2019;87:e00851-18. [PMID: 30670556 DOI: 10.1128/IAI.00851-18] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
8 Tang Y, Kline KT, Zhong XS, Xiao Y, Lian H, Peng J, Liu X, Powell DW, Tang G, Li Q. Chronic colitis upregulates microRNAs suppressing brain-derived neurotrophic factor in the adult heart. PLoS One 2021;16:e0257280. [PMID: 34543287 DOI: 10.1371/journal.pone.0257280] [Reference Citation Analysis]
9 Rahmani P, Rasti G, Gorgi M, Motamed F, Sharifi P. Extraintestinal manifestation of inflammatory bowel disease and associated factors in pediatric patients. Annals of Medicine and Surgery 2022;75:103363. [DOI: 10.1016/j.amsu.2022.103363] [Reference Citation Analysis]
10 Jang HM, Baek HS, Kim JE, Kim JY, Lee YH, Cho HY, Choe YH, Kang B, Choe BH, Choi BS, Cho MH. Renal involvement in children and adolescents with inflammatory bowel disease. Korean J Pediatr 2018;61:327-31. [PMID: 30304912 DOI: 10.3345/kjp.2018.06485] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
11 Niu GC, Liu L, Zhang XL. Hepatobiliary complications of inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2012; 20(8): 662-669 [DOI: 10.11569/wcjd.v20.i8.662] [Reference Citation Analysis]
12 Ott C, Takses A, Obermeier F, Schnoy E, Müller M. Smoking increases the risk of extraintestinal manifestations in Crohn's disease. World J Gastroenterol 2014; 20(34): 12269-12276 [PMID: 25232261 DOI: 10.3748/wjg.v20.i34.12269] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
13 Jang HJ, Kang B, Choe BH. The difference in extraintestinal manifestations of inflammatory bowel disease for children and adults. Transl Pediatr 2019;8:4-15. [PMID: 30881893 DOI: 10.21037/tp.2019.01.06] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
14 Derfalvi B, Boros KK, Szabo D, Bozsaki G, Cseh A, Rudas G, Muller KE, Veres G. Joint involvement, disease activity and quality of life in pediatric Crohn’s disease – a cross-sectional study. Pediatr Rheumatol 2022;20. [DOI: 10.1186/s12969-022-00664-z] [Reference Citation Analysis]
15 Shikhare G, Kugathasan S. Inflammatory bowel disease in children: current trends. J Gastroenterol 2010;45:673-82. [PMID: 20414789 DOI: 10.1007/s00535-010-0241-5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
16 Suh JH, Degagné É, Gleghorn EE, Setty M, Rodriguez A, Park KT, Verstraete SG, Heyman MB, Patel AS, Irek M, Gildengorin GL, Hubbard NE, Borowsky AD, Saba JD. Sphingosine-1-Phosphate Signaling and Metabolism Gene Signature in Pediatric Inflammatory Bowel Disease: A Matched-case Control Pilot Study. Inflamm Bowel Dis 2018;24:1321-34. [PMID: 29788359 DOI: 10.1093/ibd/izy007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
17 Hensley A, Beales IL. Use of Cyclo-Oxygenase Inhibitors Is Not Associated with Clinical Relapse in Inflammatory Bowel Disease: A Case-Control Study. Pharmaceuticals (Basel) 2015;8:512-24. [PMID: 26371009 DOI: 10.3390/ph8030512] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
18 Moran CJ, Kaplan JL, Winter HS, Masiakos PT. Occult Blood and Perianal Examination: Value Added in Pediatric Inflammatory Bowel Disease Screening. J Pediatr Gastroenterol Nutr 2015;61:52-5. [PMID: 25651490 DOI: 10.1097/MPG.0000000000000754] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
19 Zippi M, Corrado C, Pica R, Avallone EV, Cassieri C, De Nitto D, Paoluzi P, Vernia P. Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients. World J Gastroenterol 2014; 20(46): 17463-17467 [PMID: 25516659 DOI: 10.3748/wjg.v20.i46.17463] [Cited by in CrossRef: 61] [Cited by in F6Publishing: 51] [Article Influence: 7.6] [Reference Citation Analysis]
20 Vatn MH. Natural history and complications of IBD. Curr Gastroenterol Rep. 2009;11:481-487. [PMID: 19903424 DOI: 10.1007/s11894-009-0073-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 3.3] [Reference Citation Analysis]
21 Ciccarelli F, De Martinis M, Ginaldi L. An update on autoinflammatory diseases. Curr Med Chem 2014;21:261-9. [PMID: 24164192 DOI: 10.2174/09298673113206660303] [Cited by in Crossref: 64] [Cited by in F6Publishing: 50] [Article Influence: 8.0] [Reference Citation Analysis]
22 Said HS, Suda W, Nakagome S, Chinen H, Oshima K, Kim S, Kimura R, Iraha A, Ishida H, Fujita J. Dysbiosis of salivary microbiota in inflammatory bowel disease and its association with oral immunological biomarkers. DNA Res. 2014;21:15-25. [PMID: 24013298 DOI: 10.1093/dnares/dst037] [Cited by in Crossref: 175] [Cited by in F6Publishing: 172] [Article Influence: 19.4] [Reference Citation Analysis]
23 Ejeil AL, Thomas A, Mercier S, Moreau N. Unusual gingival swelling in a 4-year-old child. Oral Surg Oral Med Oral Pathol Oral Radiol 2014;118:627-31. [PMID: 25220780 DOI: 10.1016/j.oooo.2014.05.024] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
24 Barfield E, Deshmukh F, Slighton E, Lentine J, Lu Y, Ma X, Christos PJ, Sockolow RE, Loughlin G, Pillai S. Pulmonary Manifestations in Adolescents With Inflammatory Bowel Disease. Clin Pediatr (Phila) 2020;59:573-9. [PMID: 32146830 DOI: 10.1177/0009922820910821] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Lien CH, Lin YL, Li ST, Lin CY. Skin lesion in a patient with Hirschsprung's disease complicated with short bowel syndrome: what is your diagnosis? BMJ Case Rep 2012;2012:bcr0320126078. [PMID: 22854231 DOI: 10.1136/bcr-03-2012-6078] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Kelsen JR, Russo P, Sullivan KE. Early-Onset Inflammatory Bowel Disease. Immunol Allergy Clin North Am 2019;39:63-79. [PMID: 30466773 DOI: 10.1016/j.iac.2018.08.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 5.7] [Reference Citation Analysis]
27 Gao L, Xu T, Huang G, Jiang S, Gu Y, Chen F. Oral microbiomes: more and more importance in oral cavity and whole body. Protein Cell 2018;9:488-500. [PMID: 29736705 DOI: 10.1007/s13238-018-0548-1] [Cited by in Crossref: 171] [Cited by in F6Publishing: 145] [Article Influence: 42.8] [Reference Citation Analysis]
28 Jang HJ, Suh HR, Choi S, Hong SJ, Cho SM, Choi KH, Choe BH, Kang B; Crohn's and Colitis Association in Daegu-Gyeongbuk (CCAiD). Severe Disease Activity Based on the Paris Classification Is Associated with the Development of Extraintestinal Manifestations in Korean Children and Adolescents with Ulcerative Colitis. J Korean Med Sci 2021;36:e278. [PMID: 34783212 DOI: 10.3346/jkms.2021.36.e278] [Reference Citation Analysis]
29 Ryzko J, Zdanowicz K, Lebensztejn DM, Daniluk U. Successful Treatment with Corticosteroids in an 11-Year-Old Patient with Crohn’s Disease and Myopericarditis—Case Report. Pediatric Reports 2022;14:26-31. [DOI: 10.3390/pediatric14010005] [Reference Citation Analysis]
30 Takeuchi M, Tomomasa T, Yasunaga H, Horiguchi H, Fushimi K. Descriptive epidemiology of children hospitalized for inflammatory bowel disease in Japan: Inpatient database analysis. Pediatr Int 2015;57:443-8. [PMID: 25442802 DOI: 10.1111/ped.12547] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
31 Ott C, Schölmerich J. Extraintestinal manifestations and complications in IBD. Nat Rev Gastroenterol Hepatol. 2013;10:585-595. [PMID: 23835489 DOI: 10.1038/nrgastro.2013.117] [Cited by in Crossref: 124] [Cited by in F6Publishing: 115] [Article Influence: 13.8] [Reference Citation Analysis]